Profile data is unavailable for this security.
About the company
Sosei Group Corporation is a holding company primarily engaged in the biopharmaceutical business. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.
- Revenue in JPY (TTM)15.39bn
- Net income in JPY1.05bn
- Incorporated1990
- Employees202.00
- LocationSosei Group Corp11F, PMO Hanzomon, 2-1, Koji-machiCHIYODA-KU 102-0083JapanJPN
- Phone+81 352103290
- Fax+81 352103291
- Websitehttps://soseiheptares.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ispace Inc | 989.24m | -11.40bn | 123.31bn | 220.00 | -- | -- | -- | 124.65 | -211.47 | -211.47 | 18.35 | -43.55 | -- | -- | -- | -- | -- | -- | -- | -- | 55.88 | -- | -1,152.22 | -- | 1.36 | -97.84 | 1.53 | -- | 46.74 | -- | -180.75 | -- | -- | -- |
Mochida Pharmaceutical Co Ltd | 103.26bn | 6.65bn | 128.40bn | 1.54k | 18.76 | 0.961 | 13.78 | 1.24 | 177.78 | 177.78 | 2,778.76 | 3,470.18 | 0.6414 | 2.03 | 3.47 | -- | 4.13 | 4.86 | 5.02 | 5.94 | 53.37 | 52.20 | 6.44 | 7.36 | 3.41 | -- | -- | 41.67 | -6.28 | -0.6644 | -37.09 | -5.92 | 14.62 | -1.21 |
Zeria Pharmaceutical Co Ltd | 68.38bn | 6.20bn | 133.65bn | 1.74k | 17.95 | 1.69 | 10.82 | 1.95 | 140.14 | 140.14 | 1,548.07 | 1,484.79 | 0.5274 | 1.53 | 4.14 | -- | 4.79 | 3.37 | 7.41 | 5.40 | 72.37 | 71.45 | 9.08 | 6.52 | 0.7515 | 6.27 | 0.4294 | 41.03 | 14.87 | 1.15 | 56.41 | 8.30 | 5.40 | 3.30 |
Sawai Group Holdings Co Ltd | 200.34bn | 12.67bn | 146.04bn | 2.97k | 11.55 | 0.7243 | 4.79 | 0.729 | 288.73 | 288.73 | 4,567.63 | 4,604.67 | 0.5615 | 1.47 | 3.03 | -- | 3.60 | 1.14 | 4.95 | 1.56 | 31.26 | 36.92 | 6.41 | 2.24 | 1.22 | 87.95 | 0.2558 | 80.41 | 3.37 | 3.58 | 144.81 | -2.01 | 10.06 | 0.00 |
Kissei Pharmaceutical Co Ltd | 67.49bn | 10.53bn | 150.98bn | 1.83k | 12.76 | 0.693 | 10.24 | 2.24 | 228.30 | 228.30 | 1,463.58 | 4,204.65 | 0.2939 | 1.68 | 2.96 | -- | 4.63 | 3.21 | 5.02 | 3.47 | 47.97 | 52.39 | 15.76 | 11.10 | 5.20 | -- | 0.0076 | 36.53 | 3.23 | -1.83 | -18.52 | 3.08 | 3.74 | 10.76 |
KAKEN PHARMACEUTICAL CO., LTD. | 72.98bn | 5.44bn | 168.55bn | 1.16k | 25.41 | 1.01 | 21.05 | 2.31 | 144.37 | 144.37 | 1,942.57 | 3,636.17 | 0.4403 | 2.19 | 3.69 | -- | 3.28 | 8.17 | 3.75 | 9.56 | 54.20 | 55.55 | 7.45 | 16.09 | 4.53 | -- | 0.0274 | 44.00 | -4.01 | -5.81 | -43.03 | -22.17 | 3.16 | 0.00 |
JCR Pharmaceuticals Co Ltd | 34.34bn | 3.77bn | 177.74bn | 816.00 | 45.44 | 3.28 | 30.73 | 5.18 | 30.16 | 30.16 | 275.36 | 418.05 | 0.3576 | 0.5361 | 2.57 | -- | 3.94 | 9.63 | 6.66 | 14.67 | 74.13 | 74.34 | 11.03 | 19.32 | 0.819 | -- | 0.3031 | 26.30 | -32.77 | 10.77 | -74.00 | 4.20 | 53.67 | 25.21 |
Takara Bio Inc | 78.14bn | 16.01bn | 200.97bn | 1.67k | 12.55 | 1.79 | 9.71 | 2.57 | 132.97 | 132.97 | 648.94 | 931.93 | 0.6381 | 1.90 | 5.29 | -- | 13.11 | 11.78 | 15.09 | 13.36 | 57.29 | 63.90 | 20.54 | 20.22 | 4.62 | 10,270.50 | 0.0086 | 24.14 | 15.43 | 19.32 | -19.33 | 46.97 | 29.87 | 56.32 |
Tsumura & Co | 140.04bn | 16.48bn | 217.69bn | 3.92k | 13.16 | 0.8595 | 7.78 | 1.55 | 215.57 | 215.57 | 1,832.13 | 3,299.43 | 0.3746 | 0.738 | 2.49 | -- | 4.65 | 4.98 | 5.64 | 6.03 | 48.76 | 53.82 | 12.41 | 12.74 | 3.53 | -- | 0.2264 | 30.97 | 8.10 | 3.51 | -12.50 | 2.59 | 6.41 | 0.00 |
Sosei Group Corp | 15.39bn | 1.05bn | 243.72bn | 202.00 | 267.11 | 4.17 | 101.13 | 15.83 | 11.08 | 11.08 | 185.73 | 710.59 | 0.1582 | -- | 11.86 | 76,202,970.00 | 1.08 | -- | 1.14 | -- | 95.26 | -- | 6.82 | -- | -- | 28.29 | 0.3392 | -- | -12.10 | -- | -62.44 | -- | -- | -- |
Sumitomo Pharma Co Ltd | 555.54bn | -74.51bn | 258.71bn | 6.99k | -- | 0.6351 | -- | 0.4657 | -187.55 | -187.55 | 1,398.33 | 1,023.80 | 0.4549 | 1.85 | 4.49 | -- | -7.92 | 1.15 | -11.21 | 1.67 | 67.79 | 72.17 | -17.41 | 2.54 | 0.7713 | -- | 0.4514 | 41.44 | -0.8019 | 3.54 | -232.08 | -- | 0.6204 | 3.13 |
Peptidream Inc | 31.40bn | 8.13bn | 306.56bn | 569.00 | 37.75 | 9.62 | 29.09 | 9.76 | 62.46 | 62.46 | 241.58 | 245.03 | 0.5613 | 4.63 | 5.83 | 55,178,160.00 | 14.54 | -- | 16.61 | -- | 64.78 | -- | 25.91 | -- | 2.39 | 3.95 | 0.386 | -- | 184.99 | -- | 193.57 | -- | -- | -- |
Hisamitsu Pharmaceutical Co Inc | 128.33bn | 11.74bn | 308.55bn | 2.77k | 24.53 | 1.10 | 18.07 | 2.40 | 147.71 | 147.71 | 1,616.13 | 3,297.55 | 0.4161 | 3.15 | 3.30 | 46,345,250.00 | 3.93 | 4.61 | 4.51 | 5.23 | 56.65 | 59.96 | 9.45 | 10.77 | 4.23 | -- | 0.0088 | 49.51 | 6.77 | -2.87 | 21.58 | -9.29 | 18.81 | 0.4831 |
Data as of Jun 09 2023. Currency figures normalised to Sosei Group Corp's reporting currency: Japanese Yen JPY
27.32%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Taiyo Pacific Partners LPas of 01 Feb 2023 | 6.73m | 8.22% |
Asset Management One Co., Ltd.as of 28 Apr 2023 | 4.24m | 5.17% |
Capital International KKas of 15 Apr 2022 | 2.92m | 3.56% |
Norges Bank Investment Managementas of 31 Dec 2022 | 1.45m | 1.77% |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 01 May 2023 | 1.33m | 1.62% |
JPMorgan Asset Management (Japan) Ltd.as of 15 May 2023 | 1.30m | 1.59% |
Ichiyoshi Asset Management Co., Ltd.as of 29 Jun 2022 | 1.25m | 1.53% |
Capital Research & Management Co. (World Investors)as of 15 Apr 2022 | 1.19m | 1.45% |
BlackRock Fund Advisorsas of 04 May 2023 | 1.03m | 1.26% |
Nikko Asset Management Co., Ltd.as of 02 May 2023 | 933.90k | 1.14% |
More ▼
Data from 19 Dec 2022 - 06 Apr 2023Source: FactSet Research Systems Inc.